Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery
- 2 May 2008
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 369 (2), 774-780
- https://doi.org/10.1016/j.bbrc.2008.02.099
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2Biomaterials, 2007
- Enhanced Bone Regeneration at a Segmental Bone Defect by Controlled Release of Bone Morphogenetic Protein-2 from a Biodegradable HydrogelTissue Engineering, 2006
- Comparison of BMP‐2 and ‐4 for rat mandibular bone regeneration at various doses1Orthodontics & Craniofacial Research, 2005
- Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(l-lactide-co-glycolide) nanospheres and fibrin gelBiomaterials, 2005
- Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbitsBiomaterials, 2005
- Bone Morphogenetic Protein 2 and Retinoic Acid Acceleratein VivoBone Formation, Osteoclast Recruitment, and Bone TurnoverTissue Engineering, 2005
- Human Osteoprogenitor Bone Formation Using Encapsulated Bone Morphogenetic Protein 2 in Porous Polymer ScaffoldsTissue Engineering, 2004
- The influence on gene-expression profiling of osteoblasts behavior following treatment with the ionic products of sintered β-dicalcium pyrophosphate dissolutionBiomaterials, 2004
- A formulation method using D, L-lactic acid oligomer for protein release with reduced initial burstJournal of Controlled Release, 1993
- Bone: Formation by AutoinductionScience, 1965